CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funders: AstraZeneca, Deutsche Krebshilfe
OpenAlex ID: W2010540445
